Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
about
Seborrhoeic dermatitis: current treatment practices.The role of T cells in psoriasis.Long-term safety of tacrolimus ointment in children treated for atopic dermatitis.Treatment of irritant and allergic contact dermatitis.Treating Alopecia Areata: Current Practices Versus New Directions.Pharmacotherapy for allergic contact dermatitis.Ascomycin and FK506: pharmacology and therapeutic potential as anticonvulsants and neuroprotectants.Comparing the efficacy of Emu oil with clotrimazole and hydrocortisone in the treatment of seborrheic dermatitis: A clinical trialPimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.Review of Atopic Dermatitis and Topical Therapies.Difficult to control atopic dermatitisIs topical tacrolimus effective in alopecia areata universalis?Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.Treatment of oral lichen planus with topical pimecrolimus 1% cream.Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus.Position paper on diagnosis and treatment of atopic dermatitis.Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients.ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients.Guidelines for treatment of atopic eczema (atopic dermatitis) part I.Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvement.Dermatotherapeutic Agents
P2860
Q34549487-0262933C-A322-49A2-B767-FDE7A25B3DDFQ35110104-07FD5DD0-B505-4EBA-BF45-5AABD8E7D5F7Q35208400-D2CBD651-11F3-4B89-8AC3-1EA99922C0EFQ35870491-9B50171E-9E36-4446-94E5-F68BA362B0F9Q36171921-C79D8F5D-B1B1-48BC-9A3F-7A172BBBADB0Q36979315-2EEF3FC8-1A42-493A-88B9-59ACDD7840C3Q37164694-B34F71F2-6E6F-438A-82EB-7D8AF1C24313Q37282796-FEC0B5FC-D395-46C1-93D7-BECE4C381709Q38123240-29406290-0E4A-4327-86B7-D3CE4969C829Q38744304-15A12B07-85C0-4237-995F-3AE5CCE306CEQ40473325-4E866497-0CF9-4FBE-9340-D95CB937A364Q44201115-EDADAC09-09C9-4F35-ACA6-ED07A2F28A2EQ44841361-231B58A3-4875-44B6-BB17-20C3DDCBE33FQ44852574-E3D59D83-7063-45CD-9FE3-565EB31B3C41Q44852591-31BFA82F-4E81-4675-B921-A8702792913EQ46460423-EE38F31A-7696-4103-AD5F-A70A26A33AF9Q46982389-A05AF8F4-13D8-4DA3-A518-79A4FA3B57B0Q47849230-8DC6183C-2F3A-46CD-8131-28CE43524005Q50927518-7BFD2065-C491-4AA6-A0FF-4621B08410FAQ53400028-D3CFEBD7-1364-4EA5-A462-A856A155C39DQ57311816-611C2F66-22C5-4F23-AE60-254DA62D10DB
P2860
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@ast
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@en
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@nl
type
label
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@ast
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@en
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@nl
prefLabel
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@ast
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@en
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@nl
P2093
P356
P1476
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
@en
P2093
Bornhövd E
Burgdorf WH
Wollenberg A
P304
P356
10.1067/MJD.2001.117525
P407
P577
2001-11-01T00:00:00Z